Two fCSs with well-repeated units but minor difference in sulfation pattern were investigated.
Both fCS-Ib and fCS-Pg could significantly improve the lipid profile of HFFD mice.
fCS-Pg was more effective in lowering blood TC, LDL and AI levels.
Both fCSs obviously lowered serum glucose and increased hepatic glycogen synthesis.
Both fCSs might be potential antihyperlipdemic drugs with liver protection effect.